Chewy Eyes Pet Health, AI and Clinics to Drive Its Next Growth Phase

Chewy is making pet health a central growth engine , targeting pharmacy, supplements, prescription diets, insurance, telemedicine and veterinary clinics. Pharmacy customers generate an estimated $300–$500 more in annual spending, while the company’s 60 clinics are outperforming expectations. Despite softer demand for discretionary pet products and below-normal pet additions, core food and medication sales remain strong. Chewy continues to target 150,000–250,000 net active-customer additions and aims for long-term high-single-digit to low-double-digit revenue growth. Chewy is using Autoship, mobile engagement and artificial intelligence to increase retention and spending while largely self-funding investments. Acquisitions in health are prioritized after reinvestment, with international expansion remaining a lower priority.

Chewy NYSE: CHWY is prioritizing U.S. health services, customer spending expansion and artificial intelligence capabilities as it seeks to build on its pet retail foundation, Chief Executive Officer Sumit Singh said during a Goldman Sachs conference fireside chat. Singh said the company’s investment in supply chain and technical infrastructure, coupled with Autoship adoption across food and medication categories, has created a more stable base for reinvestment. He characterized pet health as a roughly $50 billion total addressable market, including an estimated $12 billion to $15 billion in products such as medications, prescription diets, supplements and flea-and-tick treatments.

Chewy entered the health category in 2018 and has become the country’s largest pet pharmacy, Singh said. He added that the company is capturing about $0.70 of every dollar moving online in the pet medications and related product space. Over the past six years, Chewy added approximately $9 billion in incremental revenue, with about $4 billion coming from Chewy Health, according to Singh.

Singh said consumer enthusiasm for discretionary pet categories has softened, particularly following what he described as increased marketplace stress beginning in March and April. The company saw pressure on attachment rates, or purchases of additional products beyond core needs, and adjusted its forecast accordingly. However, he said trends have since stabilized. Adoptions and relinquishments are “roughly at parity,” while Chewy’s food and medication businesses remain strong and health services are outperforming the company’s expectations relative to its April outlook. Singh said shelter and rescue organizations account for roughly two-thirds to 70% of pet adoptions, while breeders represent the remainder. He said dogs are modestly underperforming and cats are outperforming at shelters and rescues, resulting in an overall balanced adoption picture. He also said breeders of certain popular breeds have not seen a slowdown in litter production, though puppy prices have risen. While normalized annual pet additions to the market would typically total 10 million to 12 million, Singh said the current figure is running below that level. Even so, Chewy’s gross customer additions from consumers shifting from other retailers are exceeding its 2019 gross-add levels, he said. The company continues to target 150,000 to 250,000 net active-customer additions, even if broader market conditions remain subdued. Singh said Chewy’s longer-term aspiration is high-single-digit to low-double-digit revenue growth, supported by customer a...